Breast cancer acute radiotherapy morbidity evaluated by different scoring systems

Breast Cancer Research and Treatment

Volumn 73, Issue 2, 2002, Pages 127-134

  López, Escarlata ^a   Núñez, Ma Isabel ^b   Guerrero, Ma Rosario ^b   Moral, Rosario Del ^a   Dios Luna, Juan De ^c   Rodríguez, Ma Del Mar ^a   Valenzuela, Ma Teresa ^b   Villalobos, Mercedes ^b   Almodóvar, José Mariano Ruiz De ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Breast cancer; Normal tissue damage; Radiotherapy; Reliability; Side effect scales

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; DESQUAMATION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ERYTHEMA; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; MULTIMODALITY CANCER THERAPY; OBSERVER VARIATION; PHOTOGRAPHY; PRIORITY JOURNAL; RADIATION DERMATITIS; RATING SCALE; SCORING SYSTEM; TREATMENT OUTCOME; BREAST TUMOR; EVALUATION; HOSPITALIZATION; PATHOLOGY; RADIATION EXPOSURE; RADIOTHERAPY; SKIN; STANDARD;

BREAST NEOPLASMS; EVALUATION STUDIES; FEMALE; HUMAN; MORBIDITY; OBSERVER VARIATION; RADIODERMATITIS; RADIOTHERAPY; REFERENCE STANDARDS; SEVERITY OF ILLNESS INDEX; SKIN; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME; HUMANS;

EID: 0035991540     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015296607061     Document Type: Article

References (24)

1. The role of local treatment in the cure of cancer
2. The recording of morbidity related to radiotherapy
3. The uniform reporting of treatment-related morbidity
4. Documentation of radiation-induced oral mucositis. Scoring systems
5. Scoring oral mucositis
6. Is curative radiation therapy in elderly patients limited by increased normal tissue toxicity?
7. Patient-to-patient variability in the expression of radiation-induced normal tissue injury
8. Clinical manifestations of normal-tissue damage
9. Prognostic factors for acute and late skin reactions in radiotherapy patients
10. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity?
11. Comparison between normal tissue reactions and local tumour control in head and neck cancer patients treated by definitive radiotherapy
12. DNA damage and prediction of radiation response in lymphocytes and epidermal skin human cells
13. Normal tissue radiosensitivity in breast cancer patients
14. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy
15. Towards evidence based radiation oncology: Improving the design analysis, and reporting of clinical outcome studies in radiotherapy
16. Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment?
17. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
18. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy radiotherapy
19. Describing patients' normal tissue reactions: Concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity
20. 20MHz ultrasonic imaging for quantitative assessment and documentation of early and late postradiation skin reactions in breast cancer patients
21. Early reactions as dose-limiting factors in radiotherapy
22. Organ preservation and quality of life: The quality of life of patients undergoing radiation therapy
23. Radiation response and tolerance of normal tissues
24. Acute radiation reaction and local control in breast cancer patients treated with postmastectomy radiotherapy